126068-76-6

Usage

Uses

Used in Pharmaceutical Applications:
1-(4-Methoxy-phenyl)-5-methyl-1H-pyrazole-3-carboxylic acid ethyl ester is used as a precursor or intermediate for the synthesis of various bioactive compounds and pharmaceutical drugs. Its specific properties and potential uses may vary depending on the context and application within the field of chemistry and drug development.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 1-(4-Methoxy-phenyl)-5-methyl-1H-pyrazole-3-carboxylic acid ethyl ester is utilized as a key component in the development of novel therapeutic agents. Its structural features allow for the creation of new molecules with potential medicinal properties, targeting a range of health conditions and diseases.

InChI:InChI=1/C14H16N2O3/c1-4-19-14(17)13-9-10(2)16(15-13)11-5-7-12(18-3)8-6-11/h5-9H,4H2,1-3H3

Upstream product

• 615-79-2 ethyl 2,4-diketopentanoate 
• 3471-32-7 4-Methoxyphenylhydrazine 
• 98790-58-0 ethyl (Z)-4-hydroxy-2-oxopent-3-enoate 
• 19501-58-7 4-methoxyphenylhydrazine hydrochloride 

Downstream Products

• 1020724-35-9 C₁₂H₁₂N₂O₃ 

Relevant academic research and scientific papers

Design and Synthesis of Imidazole and Triazole Pyrazoles as Mycobacterium Tuberculosis CYP121A1 Inhibitors

The emergence of untreatable drug-resistant strains of Mycobacterium tuberculosis is a major public health problem worldwide, and the identification of new efficient treatments is urgently needed. Mycobacterium tuberculosis cytochrome P450 CYP121A1 is a p

PYRAZOLOPYRIDAZINE DERIVATIVES, PREPARATION METHOD THEREOF AND COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING THE SAME

The present invention is a pyrazolopyridazine derivative. A pharmaceutical composition for preventing or treating cancer contains the pyrazolopyridazin derivative compound Hsp90 according to the present invention as an active ingredient, which can be used as Hsp90 a pharmaceutical composition for preventing or treating Hsp90-related diseases such as melanoma, brain tumor, breast cancer, lung cancer and the like. (by machine translation)

Optimization of non-ATP competitive CDK/cyclin groove inhibitors through REPLACE-mediated fragment assembly

A major challenge in drug discovery is to develop and improve methods for targeting protein-protein interactions. Further exemplification of the REPLACE (REplacement with Partial Ligand Alternatives through Computational Enrichment) strategy for generatin

Pyrazoles for the treatment of obesity and other CNS disorders

This invention relates to compounds having pharmacological activity, to compositions containing these compounds, and to a method of treatment employing the compounds and compositions. More particularly, this invention concerns certain pyrazole derivatives, their salts and solvates. These compounds have H3 histamine receptor binding activity. This invention also relates to pharmaceutical compositions containing these compounds and to a method of treating disorders in which histamine H3 receptor modulation is beneficial.